Creating
Building
Fostering
Partnering
News
EN
FR
Menu
March 22, 2021
SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche
Read article
July 17, 2020
Liminal BioSciences Broadens R&D Pipeline With Novel Preclinical Program For Eosinophilic-Driven Diseases
Read article
June 4, 2020
New Company to Advance Research into Made-in-Canada Therapy for Patients with Chronic Pain
Read article
June 4, 2020
AmorChem invests in a potential treatment for cerebral amyloid angiopathy and Alzheimer’s disease Attacking central nervous system diseases using the neuroprotective effects of the innate immune system
Read article
June 3, 2020
AmorChem Invests in the Work of Sidong Huang at McGill University Using a Novel Target to Address a SMARCA4-deficient Rare and Aggressive Form of Ovarian Cancer
Read article
May 12, 2020
Consortium Backs Netherton Syndrome Project From Sinai Health
Read article
February 24, 2020
AmorChem invests in a new gene therapy approach to help patients with a devastating orphan disease
Read article
February 12, 2020
AmorChem invests in novel approach to target Myc-driven cancers
Read article
October 17, 2019
Inversago Pharma Strengthens its Board of Directors with the Appointment of Two Industry Experts
Read article
News archive